| Literature DB >> 16439674 |
Ruth Seggewiss1, Stefania Pittaluga, Rima L Adler, F Javier Guenaga, Cole Ferguson, Ingo H Pilz, Byoung Ryu, Brian P Sorrentino, W Scott Young, Robert E Donahue, Christof von Kalle, Arthur W Nienhuis, Cynthia E Dunbar.
Abstract
We report, for the first time, a replication-defective retroviral vector-associated neoplasia in a nonhuman primate. Five years after transplantation with CD34+ cells transduced with a retroviral vector expressing enhanced green fluorescent protein (eGFP) and a drug-resistant variant of the dihydrofolate reductase gene (L22Y), a rhesus macaque developed a fatal myeloid sarcoma, a type of acute myeloid leukemia. Tumor cells contained 2 clonal vector insertions. One insertion was found in BCL2-A1, an antiapoptotic gene. This event suggests that currently available retroviral vectors may have long-term side effects, particularly in hematopoietic stem and progenitor cells.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16439674 PMCID: PMC1895280 DOI: 10.1182/blood-2005-10-4108
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113